Medicare Enrolled
Dr. Ilkcan Cokgor, M.D.
Neurology · Greenbrae, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cokgor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cokgor?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cokgor
Dr. Ilkcan Cokgor is a neurology specialist in Greenbrae, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cokgor performed 28,270 Medicare services across 3,454 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cokgor received a total of $42,471 from 103 pharmaceutical and/or device companies across 2486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cokgor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in CA
$42,471 industry payments
Medicare Practice Summary
Medicare Utilization ↗28,270
Medicare services
Top 3% in CA for neurology
3,454
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,414 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
23,650 | $5 | $8 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
781 | $107 | $216 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
682 | $112 | $232 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
551 | $153 | $310 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
496 | $140 | $352 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
453 | $152 | $417 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
427 | $78 | $157 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
323 | $5 | $15 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
254 | $51 | $130 |
| Annual depression screening | 148 | $23 | $45 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
145 | $194 | $580 |
| Chemical nerve block for trunk muscles, 6 or more Injection of a chemical agent to paralyze six or more muscles on the trunk. |
139 | $86 | $406 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
68 | $141 | $225 |
| New patient office visit, complex (60-74 min) | 66 | $179 | $437 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
41 | $182 | $583 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
24 | $98 | $224 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
22 | $113 | $270 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$42,471
Total received (2018-2024)
Avg $6,067/year across 7 years
Top 10% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
103
Companies
2,486
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$41,978 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$493 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,031
2023
$6,820
2022
$5,731
2021
$6,391
2020
$5,679
2019
$5,320
2018
$5,499
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,438
CATALYST PHARMACEUTICALS, INC.
$666
Neurocrine Biosciences, Inc.
$617
Neurelis, Inc.
$497
Alexion Pharmaceuticals, Inc.
$405
SK Life Science, Inc.
$375
PFIZER INC.
$335
UCB, Inc.
$311
Lilly USA, LLC
$300
Lundbeck LLC
$269
Amneal Pharmaceuticals LLC
$253
JAZZ PHARMACEUTICALS INC.
$207
Eisai Inc.
$179
Otsuka America Pharmaceutical, Inc.
$151
Teva Pharmaceuticals USA, Inc.
$144
Biogen, Inc.
$137
ARGENX US, INC.
$93
Octapharma USA, Inc.
$84
Sumitomo Pharma America, Inc.
$64
Kyowa Kirin, Inc.
$61
CSL Behring
$59
GENZYME CORPORATION
$47
Amgen Inc.
$42
Celgene Corporation
$41
AstraZeneca Pharmaceuticals LP
$35
SCILEX PHARMACEUTICALS INC.
$35
BANNER LIFE SCIENCES, LLC
$32
Vanda Pharmaceuticals Inc.
$31
EMD Serono, Inc.
$29
Grifols USA, LLC
$26
Azurity Pharmaceuticals, Inc.
$24
Alnylam Pharmaceuticals Inc.
$23
Merz Pharmaceuticals, LLC
$22
Top 3 companies account for 38.7% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$2,725
UCB, Inc.
$2,057
ABBVIE INC.
$1,981
AbbVie Inc.
$1,853
EMD Serono, Inc.
$1,799
Avanir Pharmaceuticals, Inc.
$1,707
Amgen Inc.
$1,700
Alexion Pharmaceuticals, Inc.
$1,432
Teva Pharmaceuticals USA, Inc.
$1,412
Biogen, Inc.
$1,287
Novartis Pharmaceuticals Corporation
$1,136
Amneal Pharmaceuticals LLC
$1,120
PFIZER INC.
$990
CSL Behring
$908
Eisai Inc.
$871
Neurelis, Inc.
$866
Lilly USA, LLC
$832
Allergan, Inc.
$813
Sunovion Pharmaceuticals Inc.
$773
JAZZ PHARMACEUTICALS INC.
$745
Biohaven Pharmaceutical Holding Company Ltd.
$723
Biohaven Pharmaceuticals, Inc.
$723
CATALYST PHARMACEUTICALS, INC.
$709
Supernus Pharmaceuticals, Inc.
$673
Greenwich Biosciences, Inc.
$640
ACADIA Pharmaceuticals Inc
$630
Bausch Health US, LLC
$625
US WorldMeds, LLC
$618
GENZYME CORPORATION
$594
Lundbeck LLC
$557
Sumitomo Pharma America, Inc.
$524
Acorda Therapeutics, Inc
$504
SK Life Science, Inc.
$468
Otsuka America Pharmaceutical, Inc.
$405
Mallinckrodt Hospital Products Inc.
$392
Janssen Pharmaceuticals, Inc
$375
IMPEL PHARMACEUTICALS INC.
$363
EISAI INC.
$352
Allergan Inc.
$346
ARBOR PHARMACEUTICALS, INC.
$346
Kyowa Kirin, Inc.
$299
Adamas Pharmaceuticals, Inc.
$295
ARGENX US, INC.
$256
Catalyst Pharmaceuticals, Inc.
$247
Genentech USA, Inc.
$230
Celgene Corporation
$227
Impax Laboratories, Inc.
$214
Mallinckrodt LLC
$209
Octapharma USA, Inc.
$188
Takeda Pharmaceuticals U.S.A., Inc.
$163
Boston Scientific Corporation
$140
Merz Pharmaceuticals, LLC
$134
Axsome Therapeutics, Inc.
$127
Mallinckrodt Enterprises LLC
$126
Upsher-Smith Laboratories LLC
$126
MITSUBISHI TANABE PHARMA AMERICA, INC.
$101
Abbott Laboratories
$95
Merck Sharp & Dohme LLC
$94
GE HealthCare
$93
PORTOLA PHARMACEUTICALS, INC.
$79
Grifols USA, LLC
$74
SCILEX PHARMACEUTICALS INC.
$73
Chiesi USA, Inc.
$66
Almatica Pharma LLC
$62
Arbor Pharmaceuticals, Inc.
$62
Avion Pharmaceuticals
$58
E.R. Squibb & Sons, L.L.C.
$57
Vertical Pharmaceuticals, LLC
$53
AstraZeneca Pharmaceuticals LP
$52
Alnylam Pharmaceuticals Inc.
$48
Harmony Biosciences LLC
$48
Assertio Therapeutics, Inc.
$44
Alfasigma USA, Inc.
$43
ASSERTIO THERAPEUTICS, Inc.
$40
HARMONY BIOSCIENCES LLC
$38
Banner Life Sciences, LLC
$37
Scilex Pharmaceuticals Inc.
$36
GE Healthcare
$35
BANNER LIFE SCIENCES, LLC
$32
MERZ NORTH AMERICA, INC.
$31
Vanda Pharmaceuticals Inc.
$31
GE HEALTHCARE
$29
Strongbridge US INC.
$26
MDD US Operations, LLC
$25
Xeris Pharmaceuticals, Inc.
$24
Azurity Pharmaceuticals, Inc.
$24
AbbVie, Inc.
$22
Merck Sharp & Dohme Corporation
$21
SANOFI-AVENTIS U.S. LLC
$21
AQUESTIVE THERAPEUTICS, INC.
$20
ITI, Inc.
$20
Medtronic USA, Inc.
$20
Currax Pharmaceuticals LLC
$20
InSightec,Inc
$19
NEUROPACE, INC.
$19
Cala Health, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$17
Promius Pharma LLC
$16
Egalet US Inc
$16
UPSHER-SMITH LABORATORIES LLC
$15
Horizon Therapeutics plc
$14
Neuronetics, Inc.
$12
Ipsen Biopharmaceuticals, Inc
$11
Top 3 companies account for 15.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · Banzel · Briviact · CALA TRIO · CAPLYTA · CLEVIPREX · CONTRAVE · CREXONT · Cambia · DUOPA · Dayvigo · Dhivy · Duopa · Dysport · ELYXYB · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · EVUSHELD · Edarbi · Epidiolex · Evekeo · Evrysdi · Exablate · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NAPRELAN · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PONVORY · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · REYVOW · RNS Neurostimulator Kit · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · STRENSIQ · SUNOSI · SYMPAZAN · Soliris · Strensiq · Sunosi · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAINUA · WAKIX · WATCHMAN · Wakix · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zelnorm · Zembrace · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology in CA.
Geographic Context
Neurologists within 10 mi
193
Per 100K population
74.6
County median income
$142,785
Nearest hospital
MARINHEALTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cokgor is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 10% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cokgor experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Cokgor performed 23,650 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cokgor receive payments from pharmaceutical companies?
Yes. Dr. Cokgor received a total of $42,471 from 103 companies across 2,486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cokgor's costs compare to other neurologists in Greenbrae?
Dr. Cokgor's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cokgor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Greenbrae
Browse neurologists in Greenbrae ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology